These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

936 related items for PubMed ID: 15277330

  • 1. Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.
    Augé N, Maupas-Schwalm F, Elbaz M, Thiers JC, Waysbort A, Itohara S, Krell HW, Salvayre R, Nègre-Salvayre A.
    Circulation; 2004 Aug 03; 110(5):571-8. PubMed ID: 15277330
    [Abstract] [Full Text] [Related]

  • 2. Role for furin in tumor necrosis factor alpha-induced activation of the matrix metalloproteinase/sphingolipid mitogenic pathway.
    Tellier E, Nègre-Salvayre A, Bocquet B, Itohara S, Hannun YA, Salvayre R, Augé N.
    Mol Cell Biol; 2007 Apr 03; 27(8):2997-3007. PubMed ID: 17283058
    [Abstract] [Full Text] [Related]

  • 3. 7-Ketocholesterol and cholesterol-5alpha,6alpha-epoxide induce smooth muscle cell migration and proliferation through the epidermal growth factor receptor/phosphoinositide 3-kinase/Akt signaling pathways.
    Liao PL, Cheng YW, Li CH, Wang YT, Kang JJ.
    Toxicol Lett; 2010 Aug 16; 197(2):88-96. PubMed ID: 20466046
    [Abstract] [Full Text] [Related]

  • 4. Red wine polyphenolic compounds strongly inhibit pro-matrix metalloproteinase-2 expression and its activation in response to thrombin via direct inhibition of membrane type 1-matrix metalloproteinase in vascular smooth muscle cells.
    Oak MH, El Bedoui J, Anglard P, Schini-Kerth VB.
    Circulation; 2004 Sep 28; 110(13):1861-7. PubMed ID: 15364805
    [Abstract] [Full Text] [Related]

  • 5. Letter regarding article by Augé et al., "Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation".
    Izgi C, Cevik C, Ozkan M.
    Circulation; 2005 Feb 01; 111(4):e38-9; author reply e38-9. PubMed ID: 15687119
    [No Abstract] [Full Text] [Related]

  • 6. Oxidized LDL-induced smooth muscle cell proliferation involves the EGF receptor/PI-3 kinase/Akt and the sphingolipid signaling pathways.
    Auge N, Garcia V, Maupas-Schwalm F, Levade T, Salvayre R, Negre-Salvayre A.
    Arterioscler Thromb Vasc Biol; 2002 Dec 01; 22(12):1990-5. PubMed ID: 12482824
    [Abstract] [Full Text] [Related]

  • 7. Tissue factor binding of activated factor VII triggers smooth muscle cell proliferation via extracellular signal-regulated kinase activation.
    Cirillo P, Calì G, Golino P, Calabrò P, Forte L, De Rosa S, Pacileo M, Ragni M, Scopacasa F, Nitsch L, Chiariello M.
    Circulation; 2004 Jun 15; 109(23):2911-6. PubMed ID: 15173027
    [Abstract] [Full Text] [Related]

  • 8. E-cadherin/beta-catenin/T-cell factor pathway is involved in smooth muscle cell proliferation elicited by oxidized low-density lipoprotein.
    Bedel A, Nègre-Salvayre A, Heeneman S, Grazide MH, Thiers JC, Salvayre R, Maupas-Schwalm F.
    Circ Res; 2008 Sep 26; 103(7):694-701. PubMed ID: 18703780
    [Abstract] [Full Text] [Related]

  • 9. MAO-A-induced mitogenic signaling is mediated by reactive oxygen species, MMP-2, and the sphingolipid pathway.
    Coatrieux C, Sanson M, Negre-Salvayre A, Parini A, Hannun Y, Itohara S, Salvayre R, Auge N.
    Free Radic Biol Med; 2007 Jul 01; 43(1):80-9. PubMed ID: 17561096
    [Abstract] [Full Text] [Related]

  • 10. Plasmin-induced smooth muscle cell proliferation requires epidermal growth factor activation through an extracellular pathway.
    Roztocil E, Nicholl SM, Galaria II, Davies MG.
    Surgery; 2005 Aug 01; 138(2):180-6. PubMed ID: 16153425
    [Abstract] [Full Text] [Related]

  • 11. Oxidized low-density lipoproteins stimulate extracellular matrix metalloproteinase Inducer (EMMPRIN) release by coronary smooth muscle cells.
    Haug C, Lenz C, Díaz F, Bachem MG.
    Arterioscler Thromb Vasc Biol; 2004 Oct 01; 24(10):1823-9. PubMed ID: 15319264
    [Abstract] [Full Text] [Related]

  • 12. Involvement of the 92-kDa gelatinase (matrix metalloproteinase-9) in the ceramide-mediated inhibition of human keratinocyte growth.
    Buisson-Legendre N, Bernard P, Bobichon H, Emonard H, Schneider C, Maquart FX, Haye B, Hornebeck W.
    Biochem Biophys Res Commun; 1999 Jul 14; 260(3):634-40. PubMed ID: 10403818
    [Abstract] [Full Text] [Related]

  • 13. Chemokines induce matrix metalloproteinase-2 through activation of epidermal growth factor receptor in arterial smooth muscle cells.
    Kodali R, Hajjou M, Berman AB, Bansal MB, Zhang S, Pan JJ, Schecter AD.
    Cardiovasc Res; 2006 Feb 15; 69(3):706-15. PubMed ID: 16343467
    [Abstract] [Full Text] [Related]

  • 14. Remnant lipoprotein-induced smooth muscle cell proliferation involves epidermal growth factor receptor transactivation.
    Kawakami A, Tanaka A, Chiba T, Nakajima K, Shimokado K, Yoshida M.
    Circulation; 2003 Nov 25; 108(21):2679-88. PubMed ID: 14623816
    [Abstract] [Full Text] [Related]

  • 15. Oncostatin M, an interleukin-6 family cytokine, upregulates matrix metalloproteinase-9 through the mitogen-activated protein kinase kinase-extracellular signal-regulated kinase pathway in cultured smooth muscle cells.
    Nagata T, Kai H, Shibata R, Koga M, Yoshimura A, Imaizumi T.
    Arterioscler Thromb Vasc Biol; 2003 Apr 01; 23(4):588-93. PubMed ID: 12615664
    [Abstract] [Full Text] [Related]

  • 16. The sphingomyelin/ceramide pathway is involved in ERK1/2 phosphorylation, cell proliferation, and uPAR overexpression induced by tissue-type plasminogen activator.
    Maupas-Schwalm F, Augé N, Robinet C, Cambus JP, Parsons SJ, Salvayre R, Nègre-Salvayre A.
    FASEB J; 2004 Sep 01; 18(12):1398-400. PubMed ID: 15231724
    [Abstract] [Full Text] [Related]

  • 17. Differential regulation of ERK1/2 and p38(MAPK) by components of the Rho signaling pathway during sphingosine-1-phosphate-induced smooth muscle cell migration.
    Galaria II, Fegley AJ, Nicholl SM, Roztocil E, Davies MG.
    J Surg Res; 2004 Dec 01; 122(2):173-9. PubMed ID: 15555614
    [Abstract] [Full Text] [Related]

  • 18. Potential role for ceramide in mitogen-activated protein kinase activation and proliferation of vascular smooth muscle cells induced by oxidized low density lipoprotein.
    Augé N, Escargueil-Blanc I, Lajoie-Mazenc I, Suc I, Andrieu-Abadie N, Pieraggi MT, Chatelut M, Thiers JC, Jaffrézou JP, Laurent G, Levade T, Nègre-Salvayre A, Salvayre R.
    J Biol Chem; 1998 May 22; 273(21):12893-900. PubMed ID: 9582320
    [Abstract] [Full Text] [Related]

  • 19. Oxidized low-density lipoprotein retards the growth of proliferating cells by inhibiting nuclear translocation of cell cycle proteins.
    Zettler ME, Prociuk MA, Austria JA, Zhong G, Pierce GN.
    Arterioscler Thromb Vasc Biol; 2004 Apr 22; 24(4):727-32. PubMed ID: 14764420
    [Abstract] [Full Text] [Related]

  • 20. A key role for matrix metalloproteinases and neutral sphingomyelinase-2 in transplant vasculopathy triggered by anti-HLA antibody.
    Galvani S, Trayssac M, Augé N, Thiers JC, Calise D, Krell HW, Sallusto F, Kamar N, Rostaing L, Thomsen M, Nègre-Salvayre A, Salvayre R.
    Circulation; 2011 Dec 13; 124(24):2725-34. PubMed ID: 22082680
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.